🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH resolution without worsening fibrosis — 6 month update Page 2

MASH resolution without worsening fibrosis — 6 month update

patPC_UT Mon, Apr 20, 2026 at 4:13 PM 11 replies 565 viewsPage 2 of 3
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Apr 20, 2026 at 5:46 PM#6
DebRD_ATL said:
Liver enzyme update related to liver and MASH: I had mildly elevated ALT/AST at baseline (likely NAFLD).

Liver imaging follow-up for liver and MASH: FibroScan at baseline showed CAP score 320 dB/m (moderate steatosis) and stiffness 10.8 kPa (possible fibrosis). Diagnosed with NAFLD.

After 12 months: CAP dropped to 243 dB/m (minimal steatosis) and stiffness normalized to 5.6 kPa. Hepatologist says the liver is essentially healing itself as the metabolic stress resolves.

GLP-1 agonists may become first-line NASH therapy. The Phase 3 data on semaglutide for NASH is very promising.

Last edited: Apr 20, 2026 at 7:46 PM
10 5Dr.NateNeph, PharmD_Rodriguez, julia.endo and 7 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Apr 20, 2026 at 6:22 PM#7
patPC_UT said:
ALT was mildly raised at baseline, normalised at month five, and I now have no idea whether anything happened to the fibrosis that actually matters.

NASH/MAFLD therapeutic landscape and liver and MASH: GLP-1 agonists are emerging as potential first-line NASH therapy. The Phase 2b data for semaglutide showed 59% NASH resolution (vs 17% placebo) with 43% achieving fibrosis improvement[1].

Mechanism: GLP-1R activation reduces hepatic lipogenesis, increases fatty acid oxidation, reduces hepatic inflammation, and may directly reduce hepatic stellate cell activation (fibrosis pathway).

With resmetirom (thyroid hormone receptor agonist) recently approved for NASH, the field is evolving rapidly. Combination approaches (GLP-1 + resmetirom) are being explored.

References:
[1] Newsome PN, et al. N Engl J Med. 2021;384(12):1113-1124.
9 4raj_cambridge, ingrid_STO, pete_nash and 6 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Apr 20, 2026 at 6:58 PM#8
LibrarianMeg said:
Liver imaging follow-up for liver and MASH: FibroScan at baseline showed CAP score 320 dB/m (moderate steatosis) and stiffness 10.8 kPa (possible…

Coming at LibrarianMeg’s question from a different direction. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

Last edited: Apr 20, 2026 at 10:58 PM
8 3LarryQC_SD, wanda_boise, NurseAsh_DET and 5 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
marcus_mpls
Member
234
1,123
Nov 2024
Minneapolis, MN
Apr 20, 2026 at 7:34 PM#9

Following on from josh_phd_bmore — and this may be the naive question:

What did you change at the same time, and can you separate the two now?

7 2Dr.PathRoch, mona_PHX, andrew_nyc and 4 others
Reply Quote Save Share Report
patPC_UT
Member
212
890
Nov 2024
Park City, UT
Apr 20, 2026 at 10:28 PM#10

OP back with an update, since a thread like this is useless without one.

Coming back a few months on. It held. Nothing dramatic to report, which is the report.

Last edited: Apr 21, 2026 at 3:28 AM
39 12julia.endo, JessicaM_2024, TomFromTexas and 36 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register